Cancer BiologybioRxivPreprint
Specific Aneuploidies Predict Immune Evasion and Poor Immunotherapy Response in Melanoma
Lizabeth Katsnelson, Shini Chen, Dania Annuar…·Teresa Davoli
This study identifies chromosome 1q gain as a biomarker for poor immunotherapy response in melanoma by linking aneuploidies to immune evasion mechanisms.
DOI 10.64898/2026.04.12.718039